DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Progesterone (Progesterone) - Foetal Exposure During Pregnancy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Foetal Exposure During Pregnancy (14)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Progesterone where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-23

Patient:

Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-23

Patient:

Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-23

Patient:

Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-23

Patient:

Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-13

Patient:

Reactions: Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-13

Patient:

Reactions: Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-13

Patient:

Reactions: Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in

Reported by a physician from Poland on 2012-07-13

Patient:

Reactions: Foetal Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Drug(s) suspected as cause:
Betamethasone
    Indication: Maternal Exposure Timing Unspecified

Fenoterol Hydrobromide
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Verapamil HCL
    Indication: Maternal Exposure Timing Unspecified



Possible Progesterone side effects in male

Reported by a physician from Greece on 2012-05-09

Patient: male

Reactions: Caesarean Section, Maternal Drugs Affecting Foetus, Apgar Score LOW, Premature Baby, Foetal Exposure During Pregnancy, Gastroenteritis

Drug(s) suspected as cause:
Folic Acid
    Indication: Maternal Exposure Timing Unspecified

Paricalcitol
    Indication: Maternal Exposure Timing Unspecified

Progesterone
    Indication: Maternal Exposure Timing Unspecified

Vitamin B Complex CAP
    Indication: Maternal Exposure Timing Unspecified

Other drugs received by patient: Levocarnitine; Darbepoetin Alfa; Sevelamer Hydrochloride



Possible Progesterone side effects in male

Reported by a physician from United States on 2012-02-28

Patient: male, weighing 3.3 kg (7.3 pounds)

Reactions: Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome Neonatal

Drug(s) suspected as cause:
Neurontin
    Dosage: (600 mg bid transplacental)
    Indication: Neuropathy Peripheral
    End date: 2011-09-27

Progesterone
    Dosage: (dosing details unknown transplacental)
    Indication: Shortened Cervix
    End date: 2011-09-27

Suboxone
    Dosage: (dosing information unknown transplacental)
    Indication: Product Used FOR Unknown Indication
    End date: 2011-09-27

Xanax
    Dosage: (2 mg tid transplacental)
    Indication: Anxiety
    End date: 2011-09-27

Other drugs received by patient: Multi-Vitamins



Possible Progesterone side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-13

Patient:

Reactions: Digeorge's Syndrome, Foetal Exposure During Pregnancy, Foetal Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Aspirin
    Indication: Foetal Exposure Timing Unspecified

Dexamethasone
    Indication: Foetal Exposure Timing Unspecified

Enoxaparin Sodium
    Indication: Foetal Exposure Timing Unspecified

Humira
    Indication: Foetal Exposure Timing Unspecified

Immune Globulin Intravenous (Human)
    Indication: Foetal Exposure Timing Unspecified

Immune Globulin Intravenous (Human)

Progesterone
    Indication: Foetal Exposure Timing Unspecified



Possible Progesterone side effects in female

Reported by a health professional (non-physician/pharmacist) from Belgium on 2011-11-28

Patient: female

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Bradycardia, Cardiac Arrest, Apnoea

Adverse event resulted in: death

Drug(s) suspected as cause:
Progesterone



Possible Progesterone side effects in female

Reported by a health professional (non-physician/pharmacist) from Belgium on 2011-11-18

Patient: female

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Bradycardia, Apnoea, Cardiac Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Progesterone



Possible Progesterone side effects in female

Reported by a consumer/non-health professional from Brazil on 2011-11-02

Patient: female

Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nuvaring
    Dosage: unk;trpl
    Indication: Pregnancy
    Start date: 2010-10-17
    End date: 2010-11-19

Progesterone
    Dosage: unk;trma
    Indication: Menometrorrhagia
    Start date: 2011-01-01
    End date: 2011-06-01

Progesterone
    Dosage: unk;trma
    Indication: Placental Disorder
    Start date: 2011-01-01
    End date: 2011-06-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017